OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
Jill Wechsler is Pharm Exec's Washington Corespondent
Seek pared-down measure in funding bill to avert shutdown.
Agency officials express associated concerns around clinical trial data reliability and quality.
Administration launches national manufacturing initiative, with aim to reduce US reliance on biomedicine from China and other regions.
In countdown to renewal deadline, agency already feeling the effects of still-unclear legislative fate.
Pharma loses battle to block price negotiations, but implementation faces many challenges.
Democrats approve curbs for Medicare plans, but not for commercial drug coverage.